Who we are
Manifesto 2024
Key topics
Publications
- EXTERNAL RESOURCES
- FACTSHEETS
- INFOGRAPHICS
- PODCAST
- POLICY
- REPORTS
- VIDEOS
Newsroom
- IN THE NEWS
- PRESS RELEASES
Contact us

Login

Login

Generic medicines
- Home
- Medicines for Europe
- Did you know?
- What’s new
  - FACTSHEETS
  - POLICY
  - REPORTS
  - VIDEOS
  - INFOGRAPHICS
- Our 5 pillars
  - Patients
  - QUALITY
  - VALUE
  - SUSTAINABILITY
  - PARTNERSHIP
- Find out more
  - Related links
  - Contact us
- Twitter
Biosimilar medicines
Value added medicines
- Home
- Who we are
- Did you know?
- What’s new
  - FACTSHEETS
  - POLICY
  - REPORTS
  - VIDEOS
  - INFOGRAPHICS
- Our 5 pillars
  - Patients
  - QUALITY
  - VALUE
  - SUSTAINABILITY
  - PARTNERSHIP
- Find out more
  - Contact us
Events

EGA Q&A on the Revised EMA Bioequivalence Requirement

To view the full report, please click here.

Generic Medicines: Essential Contributor to the Long-Term Health of Society

MEMBER OF

Contact us
Privacy Policy

Medicines for Europe AISBL
Rue d’Arlon 50
1000 Brussels Belgium
T : +32 (0)2 736 84 11

Powered by Big Smile Agency

Medicines For Europe

Who we are
Vacancies
Manifesto 2024
Key topics
Publications
Newsroom
Contact us
SECTOR GROUPS
Events